Determinant Flanking Regions and the Design of Appropriate Vaccines
L SOARES,HK DENG,IS GREWAL,V KUMAR,A MILLER,KD MOUDGIL,M PALMER,EE SERCARZ
DOI: https://doi.org/10.1111/j.1749-6632.1995.tb44437.x
1995-01-01
Abstract:Annals of the New York Academy of SciencesVolume 754, Issue 1 p. 48-56 Determinant Flanking Regions and the Design of Appropriate Vaccinesa LUIS SOARES, LUIS SOARES Department of Microbiology and Molecular Genetics University of California Los Angeles, California 90024-1489Search for more papers by this authorHONGKUI DENG, HONGKUI DENG Department of Microbiology and Molecular Genetics University of California Los Angeles, California 90024-1489Search for more papers by this authorIQBAL S. GREWAL, IQBAL S. GREWAL Department of Microbiology and Molecular Genetics University of California Los Angeles, California 90024-1489Search for more papers by this authorVIPIN KUMAR, VIPIN KUMAR Department of Microbiology and Molecular Genetics University of California Los Angeles, California 90024-1489Search for more papers by this authorALEXANDER MILLER, ALEXANDER MILLER Department of Microbiology and Molecular Genetics University of California Los Angeles, California 90024-1489Search for more papers by this authorKAMAL D. MOUDGIL, KAMAL D. MOUDGIL Department of Microbiology and Molecular Genetics University of California Los Angeles, California 90024-1489Search for more papers by this authorMARK PALMER, MARK PALMER Department of Microbiology and Molecular Genetics University of California Los Angeles, California 90024-1489Search for more papers by this authorELI E. SERCARZ, ELI E. SERCARZ Department of Microbiology and Molecular Genetics University of California Los Angeles, California 90024-1489Search for more papers by this author LUIS SOARES, LUIS SOARES Department of Microbiology and Molecular Genetics University of California Los Angeles, California 90024-1489Search for more papers by this authorHONGKUI DENG, HONGKUI DENG Department of Microbiology and Molecular Genetics University of California Los Angeles, California 90024-1489Search for more papers by this authorIQBAL S. GREWAL, IQBAL S. GREWAL Department of Microbiology and Molecular Genetics University of California Los Angeles, California 90024-1489Search for more papers by this authorVIPIN KUMAR, VIPIN KUMAR Department of Microbiology and Molecular Genetics University of California Los Angeles, California 90024-1489Search for more papers by this authorALEXANDER MILLER, ALEXANDER MILLER Department of Microbiology and Molecular Genetics University of California Los Angeles, California 90024-1489Search for more papers by this authorKAMAL D. MOUDGIL, KAMAL D. MOUDGIL Department of Microbiology and Molecular Genetics University of California Los Angeles, California 90024-1489Search for more papers by this authorMARK PALMER, MARK PALMER Department of Microbiology and Molecular Genetics University of California Los Angeles, California 90024-1489Search for more papers by this authorELI E. SERCARZ, ELI E. SERCARZ Department of Microbiology and Molecular Genetics University of California Los Angeles, California 90024-1489Search for more papers by this author First published: May 1995 https://doi.org/10.1111/j.1749-6632.1995.tb44437.xCitations: 3 a This work was supported in part by grants from the National Institutes of Health, the American Cancer Society, the Juvenile Diabetes Foundation, and the National Multiple Sclerosis Society. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Sercarz, E. E., P. V. Lehmann, A. Ametani, G. Benichou, A. Miller & K. Moudgil 1993. Dominance and crypticity of T cell antigenic determinants. Ann. Rev. Immunol. 11: 729–766. 2 Gammon, G., H. M. Geysen, R. J. Apple, E. Pickett, M. Palmer, A. Ametani & E. E. Sercarz 1991. T cell determinant structure: Cores and determinant envelopes in three mouse MHC haplotypes. J. Exp. Med. 173: 609–617. 3 Soares, L., E. Sercarz & A. Miller 1994. Vaccination of the Leishmania major susceptible BALB/c mouse I. The precise selection of peptide determinants influences CD4+ T cell subset expression. Int. Immunol. 6: 785–794. 4 Mosmann, T. R. & R. L. Coffman 1989. Th1 and Th2 cells: Different patterns of lympho-kine secretion lead to different functional properties. Ann. Rev. Immunol. 7: 145. 5 Palmer, M., G. Gammon, P. Lehmann, T. Forsthuber, J. Cogswell, R. Trezza, L. Soares & E. E. Sercarz 1995. Lack of congruence between peptides priming for proliferation and help. Submitted for publication. 6 Wraith, D. C., D. E. Smilek, J. Mitchell, L. Steinman & H. O. McDevitt 1989. Antigen recognition in autoimmune encephalomyelites and the potential for peptidemediated immunotherapy. Cell 59: 247. 7 Kumar, V., V. Bhardwaj, L. Soares, J. Alexander, A. Sette & E. Sercarz 1994. MHC-binding affinity of an antigenic determinant is crucial for the differential secretion of IL-4 or IFN-γ by T cells. Submitted for publication. 8 Grewal, I., K. Moudgil & E. Sercarz 1995. Hindrance of binding to class IIa MHC by a single amino acid residue leads to silent crypticity and lack of response to a protein antigen. Proc. Natl. Acad. Sci. USA. In press. 9 Grewal, I., S. Sadegh-Nasseri, S. Frank, S. Wilbur & E. E. Sercarz 1995. Available and potential T cell repertoires: The lack of major influence by non-MHC genes. Submitted for publication. 10 Ametani, A., A. Sette & E. E. Sercarz 1995. Crypticity of T cell determinants: Relationship to the molecular context of the antigen and to its processing requirements. Submitted for publication. 11 Sette, A., L. Adorini, S. M. Colon, S. Buus & H. M. Grey 1989. Capacity of intact proteins to bind to MHC class II molecules. J. Immunol. 143: 1265–1267. 12 Jensen, P. E. 1993. Acidification and disulfide reduction can be sufficient to allow intact proteins to bind class II MHC. J. Immunol. 150: 3347–3365. 13 Janeway, C. A., M. J. Mamula & A. Y. Rudensky 1993. Rules for peptide presentation by MHC class II molecules. Int. Rev. Immunol. 10: 301–311. 14 Chicz, R M., R G. Urban, J. Gorga, W. S. Lane, L. J. Stern, D. A. A. Vignali & J. L. Strominger 1992. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358: 764–768. 15 Bhardwaj, V., V. Kumar, H. M. Geysen & E. E. Sercarz 1992. Subjugation of dominant immunogenic determinants within a chimeric peptide. Eur. J. Immunol. 22: 2009–2016. 16 Deng, H-K., R. Apple, M. Clare-Salzler, S. Trembleau, D. Mathis, L. Adorini & E. E. Sercarz 1993. Determinant capture as mechanism of protection afforded by MHC class II molecules in insulin-dependent diabetes mellitus. J. Exp. Med. 178: 1675–1680. 17 Benichou, G., E. Fedoseyeva, C. A. Olson, H. M. Geysen, M. McMillan & E. E. Sercarz 1994. Disruption of the determinant hierarchy on a self-MHC peptide: Concomitant tolerance induction to the dominant determinant and priming to the cryptic self-determinant. Int. Immunol. 6: 131–138. 18 Moudgil, K. D. & E. E. Sercarz 1993. Dominant determinants in hen eggwhite lysozyme correspond to the cryptic determinants within its self-homolog, mouse lysozyme: Implications in shaping of the T cell repertoire and autoimmunity. J. Exp. Med. 178: 2131–2138. 19 Gammon, G., J. Klotz, D. Ando & E. Sercarz 1990. The T cell repertoire to a multideterminant antigen: Clonal heterogeneity of the T cell response, variation between syngeneic individuals and in vitro selection of T cell specificities. J. Immunol. 144: 1571–1577. Citing Literature Volume754, Issue1Combined Vaccines and Simultaneous Administration: Current Issues and PerspectivesMay 1995Pages 48-56 ReferencesRelatedInformation